Thromb Haemost 2021; 121(01): 004-006
DOI: 10.1055/s-0040-1721778
Invited Editorial Focus

Waves of SARS-CoV-2 Infection and Blood Coagulation—A Link and Beyond

Job Harenberg
1  Medical Faculty Mannheim, Ruprecht-Karls-University, Heidelberg, Germany
2  DOASENSE GmbH, Heidelberg, Germany
Francesco Violi
2  DOASENSE GmbH, Heidelberg, Germany
› Author Affiliations

Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis

In 2020, the coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) presented a major health problem, forcing people to work from home in an effort to contain the virus. The pandemic generated opportunities for research in many areas. In the first phase of the pandemic, a great number of scientific reports were published on SARS-CoV-2. These reports generated further scientific questions, which have become even more relevant now that we are experiencing a second wave of infections. Thromboembolic events contribute to up to 20% of COVID-19-related mortality,[1] making this a highly important research topic.

Publication History

Received: 16 November 2020

Accepted: 17 November 2020

Publication Date:
21 January 2021 (online)

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany